OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthritis: preliminary results of an open-label, long-term extension study
Hermine I. Brunner, Jonathan Akikusa, Eslam Al‐Abadi, et al.
Annals of the Rheumatic Diseases (2024), pp. ard-225094
Open Access | Times Cited: 7
Hermine I. Brunner, Jonathan Akikusa, Eslam Al‐Abadi, et al.
Annals of the Rheumatic Diseases (2024), pp. ard-225094
Open Access | Times Cited: 7
Showing 7 citing articles:
Tofacitinib treatment of systemic juvenile idiopathic arthritis: a case report and literature review
Meifang Zhu, Yan Zhao, Xiaohua Zhang, et al.
Frontiers in Pediatrics (2025) Vol. 13
Open Access | Times Cited: 1
Meifang Zhu, Yan Zhao, Xiaohua Zhang, et al.
Frontiers in Pediatrics (2025) Vol. 13
Open Access | Times Cited: 1
Annals of the Rheumatic Diseases Collection on juvenile idiopathic arthritis (JIA) 2019-2024
Lianne Kearsley‐Fleet, Samantha Smith, Athimalaipet V Ramanan, et al.
Annals of the Rheumatic Diseases (2025)
Closed Access
Lianne Kearsley‐Fleet, Samantha Smith, Athimalaipet V Ramanan, et al.
Annals of the Rheumatic Diseases (2025)
Closed Access
Therapeutic Potential of Janus Kinase Inhibitors in Juvenile Idiopathic Arthritis
Yixuan Li, Chen Dong, Brian Shiian Chen, et al.
International Journal of Rheumatic Diseases (2025) Vol. 28, Iss. 2
Closed Access
Yixuan Li, Chen Dong, Brian Shiian Chen, et al.
International Journal of Rheumatic Diseases (2025) Vol. 28, Iss. 2
Closed Access
Physiologically Based Pharmacokinetic Modeling of Tofacitinib: Predicting Drug Exposure and Optimizing Dosage in Special Populations and Drug–Drug Interaction Scenarios
Zhihai Cao, Zilong Wang, Qian Zhang, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 425-425
Open Access
Zhihai Cao, Zilong Wang, Qian Zhang, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 425-425
Open Access
Advances in pharmacotherapy of juvenile idiopathic arthritis
Stephanie Wong, Simone Appenzeller, Marinka Twilt
Expert Opinion on Pharmacotherapy (2025)
Closed Access
Stephanie Wong, Simone Appenzeller, Marinka Twilt
Expert Opinion on Pharmacotherapy (2025)
Closed Access
Juvenile Spondyloarthropathies: Diagnostic and Therapeutic Advances—A Narrative Review
Călin Lazăr, Mirela Crișan, Oana Iulia Man, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 9, pp. 3166-3166
Open Access
Călin Lazăr, Mirela Crișan, Oana Iulia Man, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 9, pp. 3166-3166
Open Access
Effect of the Janus kinase inhibitor tofacitinib in the treatment of juvenile scleroderma: A single‐center experience
Lara Colussi, Arianna Dagri, Serena Pastore, et al.
International Journal of Rheumatic Diseases (2024) Vol. 27, Iss. 8
Closed Access
Lara Colussi, Arianna Dagri, Serena Pastore, et al.
International Journal of Rheumatic Diseases (2024) Vol. 27, Iss. 8
Closed Access
Amenorrhea in an Adolescent Female as a Rare Adverse Event of Upadacitinib Treatment for Atopic Dermatitis
Yan Teng, Yi Tang, Yibin Fan, et al.
Patient Preference and Adherence (2024) Vol. Volume 18, pp. 2307-2310
Open Access
Yan Teng, Yi Tang, Yibin Fan, et al.
Patient Preference and Adherence (2024) Vol. Volume 18, pp. 2307-2310
Open Access
